These results are in keeping with a role for the HIF-1α N-terminal activation domain in the specific activation of the CA9 gene and the HIF-2α C-terminal activation domain in activating the PHD3 gene in RCC. This evidence concerns the gene HIF1A and renal cell carcinoma.